SCHEMBL19081957

SCHEMBL19081957

c1cc(-c2c3ccccc3c(-c3cccc4ccccc34)c3ccccc23)cc(-c2cc3oc4ccc5ccccc5c4c3c3sc4ccccc4c23)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 4/20 0.34
ABCG2 Q9UNQ0 2/20 0.34
PAX8 Q06710 2/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1A2 P05177 1/20 0.34
FYN P06241 1/20 0.34
MAPK3 P27361 1/20 0.34
ALOX5 P09917 1/20 0.34
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TP53 P04637 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
NQO1 P15559 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17945710 0.84 ALOX5 (0.38) CYP1A1CYP1A2ALOX5MAPTALDH1A1
SCHEMBL19082279 0.84 ALOX5 (0.34) CYP1A1ALOX5MEN1MAPTKMT2A
SCHEMBL19082067 0.83 S1PR5 (0.37) AHRABCG2PAX8ALOX5PRKDC
SCHEMBL19076802 0.83 ALOX5 (0.40) ALOX5MEN1MAPTKMT2AALDH1A1
SCHEMBL19082063 0.82 CYP1A1 (0.36) ABCG2CYP1A1CYP1A2ALOX5PRKDC
SCHEMBL19081955 0.82 CYP1A1 (0.34) ABCG2CYP1A1CYP1A2ALOX5MAPT
SCHEMBL17945712 0.82 ALOX5 (0.40) CYP1A1ALOX5MAPTNQO1NQO2
SCHEMBL22541877 0.81 AHR (0.42) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL20127331 0.81 AHR (0.42) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL19081561 0.81 TDP1 (0.36) AHRABCG2PAX8CYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 AHR 2453/4885ABCG2 4823/4885PAX8 2336/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 AHR 2453/4885ABCG2 4823/4885PAX8 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.